1-hydroxymethylmidazolam has been researched along with flumazenil in 1 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (flumazenil) | Trials (flumazenil) | Recent Studies (post-2010) (flumazenil) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 4,673 | 426 | 981 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, TM; Ha, HR; Haberthür, C; Haefeli, WE; Hunkeler, W; Ritz, R; Scollo-Lavizzari, G; Sleight, AJ | 1 |
1 other study(ies) available for 1-hydroxymethylmidazolam and flumazenil
| Article | Year |
|---|---|
Prolonged sedation due to accumulation of conjugated metabolites of midazolam.
Topics: Aged; Aged, 80 and over; Animals; Coma; Electroencephalography; Female; Flumazenil; Glucuronates; Humans; Liver Function Tests; Male; Midazolam; Middle Aged; Prospective Studies; Rats; Receptors, GABA-A; Renal Insufficiency | 1995 |